Sofija Jovic, PhD, MBA
Chief Executive Officer
Chief Executive Officer, Dr. Sofija Jovic, leads the long-term strategic direction of the company and oversees its development, both in terms of expansion of operational and scientific capabilities and the increase in company’s visibility and impact in the industry. Her focus is to position ProPhase as the thought leader in using measurement science to transform clinical trials, with a particular emphasis on improving outcomes for all stakeholders: research sponsors, investigators, as well as patients and caregivers.
In her previous role of President and Chief Operating Officer, Dr. Jovic guided the company through its transformation from a four-person start-up to a global industry leader in providing expert measurement services to the pharmaceutical industry. During this time, ProPhase experienced an exponential growth in market share, with increased depth and breadth of services offered. In collaboration with Dr. Mark Opler, the former CEO and current CSO of the company, Dr. Jovic enabled this growth by developing a leadership team that grew with the company and focusing on enhancing competitive differentiators that sustain ProPhase’s high client loyalty.
Dr. Jovic started her career as a clinical psychologist: teaching, conducting research and providing testing and treatment at a variety of treatment settings. Dr. Jovic has published in peer-reviewed journals and presented scientific papers at professional and industry conferences. She is a member of the American Psychological Association (APA), Anxiety Disorders Association of America (ADAA), The International Society for CNS Drug Development (ISCDD), The International Society for CNS Clinical Trials and Methodology (ISCTM), American Society for Clinical Psychopharmacology (ASCP) and is a founding member of CNS Summit.
Dr. Jovic earned her PhD in Clinical Psychology from Long Island University and her Master’s in Business Administration from Massachusetts Institute of Technology, Sloan School of Management.